Financials
- Market Capitalization 259.99 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.36
ratio cours/chiffre d'affaires
2.41
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3338 | EYPT EyePoint, Inc. - Common Stock | 2.98 USD | -2.93% | -9.70% | -30.21% | -75.17% | 256.91 M USD | ||
| 3351 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.06 USD | +0.49% | +11.96% | +128.89% | +108.08% | 262.15 M USD | ||
| 3355 | ABEO Abeona Therapeutics Inc. - Common Stock | 4.42 USD | -2.21% | -12.13% | -18.45% | -17.38% | 252.75 M USD | ||
| 3357 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.52 USD | -3.08% | -9.68% | -30.00% | -15.15% | 249.85 M USD |